Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Vietnam”. It is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Vietnam, identifying key trends in the healthcare market and providing insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market, using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

In 2015, Vietnam’s population stood at 92 million, an increase from 85 million in 2008 due to the high birth rate and low mortality rate. The country’s pharmaceutical market was estimated to have been worth $3.5 billion in 2015 and is expected to reach $6.6 billion by 2020 at a projected Compound Annual Growth Rate (CAGR) of 13.8%. The medical device market was estimated at approximately $295m in 2015 and is expected to grow at a CAGR of 11.3% to $505m by 2020.

The positive trends in Vietnam’s healthcare market can primarily be attributed to -

  • Increasing coverage of healthcare insurance
  • Government initiatives to improve healthcare facilities
Scope

The report includes -
  • Overview of the pharmaceutical and medical device markets, including size, segmentation and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Hau Giang Pharmaceuticals (DHG Pharmaceuticals), Imexpharm, Traphaco and Domesco.
  • An insightful review of the reimbursement and regulatory landscape, covering the healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy

The report will enhance your decision-making capability by allowing you to -
  • Develop business strategies through an understanding of the trends shaping and driving the healthcare market
  • Drive revenue by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical device market segments and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in the healthcare market


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 GlobalData
Report Guidance
3 Overview of the Pharmaceutical and Medical Device Markets
3.1 Pharmaceutical Market
3.1.1 Market Overview
3.1.2 Pharmaceutical Exports and Imports
3.1.3 Supply Channels
3.1.4 Market Segments
3.1.5 Major Disease Areas
3.1.6 Major Companies
3.2 Medical Device Market
3.3 Market Drivers and Barriers
3.3.1 Drivers
3.3.2 Barriers
4 Market Access
4.1 Reimbursement and Payer Landscape
4.1.1 Overview of Healthcare System
4.1.2 Reimbursement Process
4.1.3 Overview of Insurance Providers
4.1.4 Patient Share in Healthcare Spending
4.1.5 Price Trends in Healthcare Sector
4.1.6 Pricing Policies
4.2 Regulatory Landscape
4.2.1 Overview of Regulatory Agencies
4.2.2 Market Authorization Procedure for Pharmaceutical Products
4.2.3 New Medical Device Approval Process
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
4.2.5 Licensing Process for Pharmaceutical Exports and Imports
4.2.6 Intellectual Property Rights
4.2.7 Clinical Trial Regulations
4.2.8 Pharmaceutical Advertising Regulations
4.2.9 Pharmacy Regulations
4.2.10 Labeling and Packaging Regulations
5 Country Analysis
5.1 Political Environment
5.1.1 Political Structure
5.1.2 Analysis of the Current Political Environment
5.1.3 Healthcare Policy Initiatives
5.2 Economic Landscape
5.3 Economic Indicators
5.3.1 Gross Domestic Product
5.3.2 Gross National Income
5.3.3 Inflation
5.3.4 Currency Exchange Rate
5.3.5 Foreign Direct Investment
5.3.6 Foreign Exchange Reserves
5.3.7 Trade Balance
5.3.8 General Government Structural Balance
5.3.9 General Government Net Debt
5.3.10 Major Industries
5.4 Demographics
5.4.1 Population
5.4.2 Education and Literacy
5.4.3 Employment
5.4.4 Disease Burden
5.5 Healthcare Infrastructure
5.5.1 Healthcare Facilities
5.5.2 Healthcare Parameters
5.5.3 Environmental Health
5.5.4 Healthcare Personnel
5.6 Healthcare Expenditure
5.6.1 Overview
5.6.2 Major Components of Healthcare Spending
5.6.3 Public and Private Sector Share
5.6.4 Spending in Healthcare R&D
5.7 Trade Associations
5.7.1 Vietnam Pharmaceutical Companies Association
5.7.2 Vietnam General Association of Medicine and Pharmacy
5.7.3 Vietnam Public Health Association
5.8 Trade Fairs
6 Opportunities and Challenges
6.1 Opportunities
6.2 Challenges
7 Appendix
7.1 Abbreviations
7.2 Bibliography
7.3 Research Methodology
7.3.1 Coverage
7.3.2 Secondary Research
7.3.3 Forecasts
7.3.4 Expert Panel
7.4 Disclaimer
1.1 List of Tables
Table 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015
Table 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020
Table 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015
Table 4: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015
Table 5: OTC Market, Vietnam, Revenue ($m), 2008-2015
Table 6: Pharmaceutical Market, Vietnam, Major Disease Areas, Prevalence and Number of Mental Disorder Cases, 2005
Table 7: Pharmaceutical Market, Sanofi, Major Products, 2015
Table 8: Pharmaceutical Market, Sanofi, Global, Late-Stage Pipeline, 2016
Table 9: Pharmaceutical Market, DHG Pharmaceutical, Major Products, 2015
Table 10: Pharmaceutical Market, Traphaco, Major Products, 2015
Table 11: Pharmaceutical Market, Domesco, Major Products, 2015
Table 12: Medical Device Market, Vietnam, Revenue ($m), 2008-2015
Table 13: Medical Device Market, Vietnam, Revenue ($m), 2016-2020
Table 14: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015
Table 15: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015
Table 16: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015
Table 17: Regulatory Landscape, Vietnam, Trademark Filing Fees and Charges, 2015
Table 18: Regulatory Landscape, Vietnam, Labeling Guidelines, 2015
Table 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015
Table 20: Economic Indicators, Vietnam, GDP per Capita Forecast ($), 2016-2020
Table 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015
Table 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020
Table 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015
Table 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015
Table 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020
Table 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015
Table 27: Economic Indicators, Vietnam Currency Exchange Rate ($/VND) 2008-2015
Table 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015
Table 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015
Table 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015
Table 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015
Table 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015
Table 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015
Table 34: Economic Indicators, Vietnam, General Government Net Debt Forecast ($bn), 2016-2020
Table 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014
Table 36: Demographics, Vietnam, Population (million), 2008-2015
Table 37: Demographics, Vietnam, Population (million), 2016-2020
Table 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015
Table 39: Demographics, Vietnam, Population, Urban and Rural Population Share Forecast (%), 2016-2020
Table 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015
Table 41: Demographics, Vietnam, Population Distribution by Age Group Forecast (%), 2016-2020
Table 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015
Table 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015
Table 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011
Table 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015
Table 46: Demographics, Vietnam, Immunization Rate (%), 2008-2013
Table 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases (‘000), 2011
Table 48: Demographics, Vietnam, Major Causes of Female Mortality (‘000), 2011
Table 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015
Table 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015
Table 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015
Table 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015
Table 53: Demographics, Vietnam, Number of Deaths by Disease (‘000), 2013
Table 54: Demographics, Vietnam, Major Diseases, DALYs (‘000), 2012
Table 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015
Table 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015
Table 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015
Table 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015
Table 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015
Table 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015
Table 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015
Table 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015
Table 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015
Table 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015
Table 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013
Table 66: Healthcare Expenditure, Vietnam, Healthcare Expenditure, Public-Private Share (%), 2008-2015
Table 67: Healthcare Expenditure, Vietnam, Major Healthcare Trade Fairs, 2016
1.2 List of Figures
Figure 1: Pharmaceutical Market, Vietnam, Revenue ($bn), 2008-2015
Figure 2: Pharmaceutical Market, Vietnam, Revenue Forecast ($bn), 2016-2020
Figure 3: Pharmaceutical Market, Vietnam, Exports and Imports ($m), 2008-2015
Figure 4: Pharmaceutical Market, Vietnam, Supply Chain, 2015
Figure 5: Pharmaceutical Market, Vietnam, Distribution channels, 2015
Figure 6: Pharmaceutical Market, Vietnam, Generic Market Revenue ($bn), 2008-2015
Figure 7: Pharmaceutical Market, Vietnam, OTC Market Revenue ($bn), 2008-2015
Figure 8: Medical Device Market, Vietnam, Revenue ($m), 2008-2015
Figure 9: Medical Device Market, Vietnam, Revenue ($m), 2016-2020
Figure 10: Healthcare Market, Vietnam, Drivers and Barriers, 2016
Figure 11: Market Access, Vietnam, Overview of Healthcare System
Figure 12: Market Access, Vietnam, Overview of Healthcare System
Figure 13: Market Access, Vietnam, Health Insurance Population Coverage (%), 2008-2015
Figure 14: Market Access, Vietnam, Out-of-Pocket Expenditure (%), 2008-2015
Figure 15: Market Access, Vietnam, Change in Average Price of Healthcare Services (%), 2008-2015
Figure 16: Market Access, Vietnam, Marketing Authorization Procedure, 2015
Figure 17: Regulatory Landscape, Vietnam, Generic Drug Approval Process, 2015
Figure 18: Market Access, Vietnam, Patent Approval Process, 2014
Figure 19: Economic Indicators, Vietnam, GDP per Capita ($), 2008-2015
Figure 20: Economic Indicators, Vietnam, GDP per Capita ($), 2016-2020
Figure 21: Economic Indicators, Vietnam, GDP Annual Growth (%), 2008-2015
Figure 22: Economic Indicators, Vietnam, GDP Annual Growth (%), 2016-2020
Figure 23: Economic Indicators, Vietnam, GNI Per Capita ($), 2008-2015
Figure 24: Economic Indicators, Vietnam, Consumer Price Index, 2008-2015
Figure 25: Economic Indicators, Vietnam, Consumer Price Index, 2016-2020
Figure 26: Economic Indicators, Vietnam, Consumer Price Annual Change (%), 2008-2015
Figure 27: Economic Indicators, Vietnam, Currency Exchange Rate ($/VND) 2008-2015
Figure 28: Economic Indicators, Vietnam, FDI ($bn), 2008-2015
Figure 29: Economic Indicators, Vietnam, Foreign Exchange Reserves ($bn), 2008-2015
Figure 30: Economic Indicators, Vietnam, Imports of Goods and Services ($bn), 2008-2015
Figure 31: Economic Indicators, Vietnam, Exports of Goods and Services ($bn), 2008-2015
Figure 32: Economic Indicators, Vietnam, Government Structural Balance ($bn), 2008-2015
Figure 33: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2008-2015
Figure 34: Economic Indicators, Vietnam, General Government Net Debt ($bn), 2016-2020
Figure 35: Economic Indicators, Vietnam, Major Industries, Population Employed (million), 2014
Figure 36: Demographics, Vietnam, Population (million), 2008-2015
Figure 37: Demographics, Vietnam, Population (million), 2016-2020
Figure 38: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2008-2015
Figure 39: Demographics, Vietnam, Population, Urban and Rural Population Share (%), 2016-2020
Figure 40: Demographics, Vietnam, Population Distribution by Age Group (%), 2008-2015
Figure 41: Demographics, Vietnam, Population Distribution by Age Group (%), 2016-2020
Figure 42: Demographics, Vietnam, Births (per 1,000 population), 2008-2015
Figure 43: Demographics, Vietnam, Mortality (per 1,000 population), 2008-2015
Figure 44: Demographics, Vietnam, Major Causes of Mortality, Number of Deaths (%), 2011
Figure 45: Demographics, Vietnam, Children under Five, Mortality Rate (per 1,000 live births), 2008-2015
Figure 46: Demographics, Vietnam, Immunization Rate (%), 2008-2015
Figure 47: Demographics, Vietnam, Major Causes of Male Mortality, Number of Cases (‘000), 2011
Figure 48: Demographics, Vietnam, Major Causes of Female Mortality, Number of Cases (‘000), 2011
Figure 49: Demographics, Vietnam, Gender Ratio (M/F), 2008-2015
Figure 50: Demographics, Vietnam, Life Expectancy at Birth (years), 2008-2015
Figure 51: Demographics, Vietnam, Gross Enrollment by Level of Education (%), 2008-2015
Figure 52: Demographics, Vietnam, Unemployment Rate (%), 2008-2015
Figure 53: Demographics, Vietnam, Number of Cases by Disease (‘000), 2012
Figure 54: Demographics, Vietnam, Major Diseases, DALYs (‘000), 2012
Figure 55: Healthcare Infrastructure, Vietnam, Health Establishments, 2008-2015
Figure 56: Healthcare Infrastructure, Vietnam, Number of Beds by Type of Establishment, 2008-2015
Figure 57: Healthcare Infrastructure, Vietnam, Hospital Beds (per 1,000 population), 2008-2015
Figure 58: Healthcare Infrastructure, Vietnam, Doctors (per 1,000 population), 2008-2015
Figure 59: Healthcare Infrastructure, Vietnam, PM2.5 (µg/m3), 2008-2015
Figure 60: Healthcare Infrastructure, Vietnam, CO2 Emissions (metric tons per capita), 2008-2015
Figure 61: Healthcare Infrastructure, Vietnam, Nurses (per 1,000 population), 2008-2015
Figure 62: Healthcare Infrastructure, Vietnam, Midwives (per 1,000 population), 2008-2015
Figure 63: Healthcare Infrastructure, Vietnam, Pharmacists (per 1,000 population), 2008-2015
Figure 64: Healthcare Expenditure, Vietnam, Healthcare Expenditure (% of GDP), 2008-2015
Figure 65: Healthcare Expenditure, Vietnam, Public Healthcare Expenditure, Share of Major Components (%), 2013
Figure 66: Healthcare Expenditure, Vietnam, Public-Private Share of Healthcare Expenditure (%), 2008-2015
Figure 67: Healthcare Market, Vietnam, Opportunities and Challenges, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report